Health Roundup: Pfizer Inc. (NYSE:PFE) Paying Charges Over Settlements of Zyvox and Lyrica

  on Dec 13,2012 Posted in Business News ,Featured
 
Share |
We're on   

Pfizer Inc. (NYSE:PFE) decided to pay a collective $42.9 million to North Carolina and 32 other states in a settlement of accusations that the drug manufacturer used biased and deceiving practices in the distribution of antibiotic Zyvox and nerve-pain medicine Lyrica.

Eli Lilly & Co. (LLY) declined more than 3% on Wednesday as the drug manufacturer reported that it was going back to the laboratory to experiment a therapy it hopes would aid Alzheimer’s patients.

Lilly is making this move instead of risk going to the Food and Drug Administration and face refusal for solanezumab, the therapy intended to help comfort dementia in patients with mild cases of Alzheimer’s.

In the other health-care components, shares of Aetna Inc. (NYSE:AET)rallied in the light of a conference kept by the insurer seemed to motivate investors, with major provisions of President Barack Obama’s health-care overhaul near to come into force.
Pfizer Inc. (NYSE:PFE) dropped of -0.51% and closed at $25.51 with the total traded volume of 29.83 million shares. PFE has trailing twelve months’ earnings per share of $1.25.

Eli Lilly & Co. (NYSE:LLY) shares moved down -3.16% to close at $49.00 and its total traded volume during last trading session was 18.76 million shares.

LLY’s has market capitalization of $56.86 million and its beta value stands at 0.68 times.  LLY’s has current ratio of 2.02 and its debt-to-equity ratio was 0.34.

Aetna Inc. (NYSE:AET) surged +3.21% with the closing price of $45.91. The overall volume in the last trading session was 8.45 million shares. Its fifty two week range was $34.58-$51.14. The total market capitalization remained $15.36 billion.

In its share capital AET has 334.50 million outstanding shares while 333.19 million shares have been floated in market. AET has insider ownership of 0.15% with its institutional ownership remained 0.15%. Company’s current year earnings per share grew with 25.01% while the five years EPS growth rate was +12.01%.

Amgen, Inc. (NASDAQ:AMGN)

As of latest close, Amgen, Inc. (NASDAQ:AMGN) shares are up about +0.24% for 2012 and recently topped out a 52-week high of $90.81 (12/13/2012). The shares slipped below the 200-Day SMA ($17.60) and are now standing 4.16% below 50-day SMA. The performance measured for the month was +5.88% and weekly performance appeared at +1.30%.

GlaxoSmithKline plc (ADR) (NYSE:GSK)

The price of the stock moved down -0.36% and finished the day at $44.21 on above average volume. The day started out with a higher opening price of $44.46 versus prior close of $44.37. The total number of shares traded on the latest trading day was about 7.01 shares. The shares surged about 2.36% since the start of 2012 and has a -2.28% lose in last three months. Narrowing down the performance period, the stock rose 4.15% for the month and a 1.59% gain over the week.

 

 

 



 

Leave a Reply